1. Introduction {#s0005}
===============

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body and has become the most important health problem due effect on morbidity and mortality ([@b0150]). Normal cancer chemotherapy has multidrug resistance (MDR) caused by overexpression of integral membrane transporters, which can decrease drug buildup inside the cell. MDR cells are resistant to cytotoxic effects of various chemotherapeutic agents ([@b0125], [@b0130]). Developing new anticancer agents that are efficient to MDR cells is a reasonable approach to overcome MDR ([@b0155]).

Anticancer drugs can destroy tumors and arrest cancer progress but cancer treatment may damage healthy cells and tissues also ([@b0025]). Thus, new anticancer agents from natural products are expected to play an important role in the development of more effective and safer drugs to inhibit the onset of cancer ([@b0060]).

Fungi contain some of the most unbelievable chemical factories known today. Accordingly, numerous bioactive agents such as mycotoxins, anticancer and antifungal agents have been reported in the literature ([@b0050], [@b0055]). Despite there are many new compounds revealing meny biological activities but still being discovered, including well-known metabolites such as griseofulvin ([@b0100], [@b0115], [@b0075], [@b0120]). The Large combinatorial libraries of fungal active compounds have not provided the estimated number of new chemical entities in addition it couldn't explains why the field of natural products is currently assuming new prominence ([@b0015]). It has been estimated that approximately 1.5 million or likely as many as 3 million fungal species exist on Earth, of which only around 100,000 species have been described so far ([@b0035], [@b0070]). A multitude of new species are likely to be discovered from miscellaneous habitats, such as soils and tropical forest plants, associated to insects and in the aquatic environment ([@b0020]).

Therefore, our aim was to study the antitumor activity of the extracts and isolated compounds from *Drechslera rostrata* and *Eurotium tonophilum* in human cancer cells.

2. Materials and methods {#s0010}
========================

Fungi under investigation \[*Drechslera rostrata* (DSM 62596) *and Eurotium tonophilum* (ATCC 16440)\] were pushed from DSMZ (German Collection of Microorganisms and Cell Cultures). For culturing the fungi malt extract agar (MEA) medium ([@b0160]) was used for cultivation of the fungal.

2.1. Fungal extraction and isolation of compounds {#s0015}
-------------------------------------------------

The mycelia mat (800 g) of each fungus (*D. rostrata* and *E. tonophilum*) was separately harvested, washed with distilled water, and extracted by refluxing in boiled ethanol (2 liter) for 3 h and filtered off, this process was repeated for three times. The combined filtrates were concentrated under reduced pressure at temperature not exceeding 35 °C. The obtained residues of *D. rostrata* (88 g) and *E. tonophilum* (90 g) were symbolized as D1 & E1.

The total extracts (22 g each) were separately dissolved in ethanol and applied on the top of column (5 × 150 cm) packed with 100 g silica gel. Elution was carried out using chloroform -methanol (95:5 v/v), 150 hundred fractions (100 ml each) were collected, the similar fractions were collected together (according to color and number of spots) and concentrated using reduced pressure as previously described, they reduced into two sub fraction for each column. Both symbolized as DF and ET for *D. rostrata* and *E. tonophilum*. respectively.

DF fractions (12 g) were collected together were individually introduced to the top of a glass column (3 × 160 cm) packed with 360 g silica gel G. Elution were carried out using system Ethyl acetate: Methanol: Water (30: 5: 4 v/v/v), 110 fractions (100 ml each) were collected; each was concentrated under reduced pressure to a small volume. Similar fractions were collected together and re-applied on to other columns for final purification. **H1** was isolated ([@b0010]).

The sub-fractions ET (9) were dissolved in ethanol and applied on the top of column (5 × 150 cm) packed with 300 g silica gel G, Benzene: ethyl acetate (86:14 v/v) was used as eluent. Sixty fractions (100 ml each) were collected, similar fraction were collected together (according to color and number of spot) and concentrated as previously described, to produced two sub-groups with semi purified compounds for final purifications each fraction was reapplied on other columns packed with silica gel G and eluted with benzene: chloroform (90:10 v/v) from which compound **H2** was isolated ([@b0010]).

2.2. Cell culture {#s0020}
-----------------

The tested human carcinoma cell lines were obtained from the American Type Culture Collection (ATCC, Rockville, MD). The cells were grown on RPMI-1640 medium supplemented with 10% heat inactivated fetal calf serum, 1% L-glutamine, and 50 µg/ml gentamycin. The cells were maintained at 37 °C in a humidified atmosphere with 5% CO~2~ incubator (Shel lab 2406, USA) and were sub-cultured two to three times a week.

2.3. Antitumor activity assay {#s0025}
-----------------------------

For antitumor assays, the tumor cell lines were suspended in buffer and added to the medium at concentration 5 × 10^4^ cell/well in Corning® 96-well tissue culture plates, then incubated for 24 h. The tested compounds were then added into 96-well plates (six replicates) to achieve seven concentrations for each compound. Six vehicle controls with media or 0.5% DMSO were run for each 96 well plate as a control. After incubating for 24 h, the numbers of viable cells were determined by the MTT test. Briefly, the media was removed from the 96 well plate and replaced with 100 µl of fresh culture RPMI 1640 medium without phenol red then 10 µl of the 12 mM MTT (Sigma) stock solution (5 mg of MTT in 1 mL of PBS) to each well including the untreated controls. The 96 well plates were then incubated at 37 °C and 5% CO~2~ for 4 h. An 85 µl aliquot of the media was removed from the wells, and 50 µl of DMSO was added to each well and mixed thoroughly with the pipette and incubated at 37 °C for 10 min. Then, the optical density was measured at 590 nm with the microplate reader (SunRise, TECAN, Inc, USA) to determine the number of viable cells.

The percentage of viability was calculated as:$$\lbrack 1 - (\text{ODt}/\text{ODc})\rbrack \times 100\%$$Where ODt is the mean optical density of wells treated with the tested sample and ODc is the mean optical density of untreated cells.

The relation between surviving cells and drug concentration is plotted to get the survival curve of each tumor cell line after treatment with the specified compound. The 50% inhibitory concentration (IC~50~), the concentration required to cause toxic effects in 50% of intact cells, was estimated from graphic plots of the dose response curve for each conc. using Graphpad Prism software (San Diego, CA, USA) ([@b0090], [@b0040]).

2.4. Statistical analysis {#s0030}
-------------------------

Data were expressed as mean ± S. D. Statistical analysis was done by using GraphPad Prism 5 (San Diego, CA, USA).

3. Results and discussion {#s0035}
=========================

3.1. Isolated compounds {#s0040}
-----------------------

Two compounds were isolated from mycelial mat of *D. rostrate* (**H1**) and *E. tonophilum* (**H2**) using different spectroscopic analysis including ^1^HNMR, ^13^CNMR, HMBC, HMQC and EI-MS ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1The isolated compounds (H1 & H2) from *Drechslera rostrata* and *Eurotium tonophilum.*

**H1:** Colorless oil, (950 mg), R~f~ = 0.40 in system (n-hexane- benzene 30:70 v/v), b.p. = 385 °C; The ESI-MS at *m*/*z* 413 \[M + Na\]+ (100%), 390 g/mol, \[M + H\]^+^ ion 391 (9.1), \[M\]^+^ 390, \[M~2~ + Na\]^+^ 803 (5.4%).^1^H-NMR in CDCl~3~: δ; 0.94 (3H, t, *J* = 7.2 Hz,H8′, H8″), 0.93 (3H, t, *J* = 7.2 Hz, H10′,H10″), 1.25--1.40 (6H, m, (H-5′,5″), (H- 6′, 6″ and (H-7′,7″), 1.50--1.42 (4H, m, H-9′,9″), 1.69 (2H, septet, *J* = 6 H~Z~, H-4′, 4″), 4.10 (2H, dd,*J ~H3′b,\ H4′~* = 6.1 H~Z~ and *J~H3′b~, ~H3′a~* = 10.9 Hz,H-3′b,3″b), 4.26 (2H,dd, *J ~H3~*~′~*~a,\ H4~*~′~ = 5.7 H~Z~ and *J~H3′a~, ~H3′b~* = 10.9 H~Z~, H-3′a,3″a), 7.6 (2H, m*,* H4,H5) and 7.74 (2H, *m,* H3,H6).^13^C-NMR and DEPT in CDCl~3~: δ; 10.97 (C-10′,10″) and 14.07 (C-8′,8″)\] δ; 22.97 (C-7′,7″), 23.24 (C-9′,9″), 28.90 (C-6′,6″) and 30.35 C-5′,5″), δ; 38.72 (C-4′,4″)\], \[*δ* 128.83 (C-3,6) and 130.86 (C-4,5), δ; 132.38 (C-1, C-2)\] δ; 168.10 (C-1′, 1″). Spectroscopic data analysis (^1^H-NMR.^13^C-NMR and DEPT COSY, HSQC and HMBC) was compared with published ([@b0110], [@b0005]), this compound is identified as; *di*-2-ethylhexyl phthalate.

**H2:** Orange to yellow needle crystals (550 mg), R~f~ = 0.67 in system (Benzene- chloroform 80:20 v/v), m.p. = 204--205 °C. ^1^H-NMR in CDCl~3~, showed at *δ* 2.45(S, CH3) at δ (3.94, S, OCH3), at *δ* 6.73 (1H, d, *J* = 2.55 Hz, H-2), *δ* 7.1 (1H, S, H-7), *δ* 7.41 (1 H, d, *J* = 2.55 Hz, H-4), *δ* 7.55 (1H, S,H-5) *δ*12.12, (S, 8-OH), *δ* 12.32 (S, 1-OH).^13^C- NMR and DEPT; the^13^C-NMR in CDCl~3~, *δ* 22.20 (CH~3~-6) and *δ* 56.12 (OCH~3~-3) *δ* 106.76, 108.25, 121.32 and 124.53\] *δ* 110.09, 113.93, 133.22, 135.23, 148.47, 162.49, 165.18, 166.53, 181.05, 190.78.By comparing the obtained spectroscopic data analysis with published ([@b0080]), this compound is identified as 1,8-Dihydroxy-3-methoxy-6-methyl- anthraquinone.

3.2. Antitumor activity assay {#s0045}
-----------------------------

The anticancer activity of *Drechslera rostrata*, *Eurotium tonophilum* extracts in addition to the isolated compounds **H1** & **H2** were evaluated on the basis of its protective effects on cell viability is shown in [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"} & [Table 1](#t0005){ref-type="table"}. The anticancer activity of Vinblastine sulphate as a reference standard was also studied and shown in [Fig. 6](#f0030){ref-type="fig"} & [Table 1](#t0005){ref-type="table"}.Fig. 2The antitumor activity of *Drechslera rostrata* extract on four cell lines.Fig. 3The antitumor activity of *Eurotium tonpholium* extract on four cell lines.Fig. 4The antitumor activity of compound H1 on four cell lines.Fig. 5The antitumor activity of compound H2 on four cell lines.Table 1The IC~50~ values of *Drechslera rostrata* and *Eurotium tonophilum* extracts and isolated compounds on four cell lines.Tested extractCell lineIC~50~ (µg/ml)HCT-116 (Colon carcinoma)Hela (Cervical carcinoma)HEp-2 (Larynx carcinoma)HepG-2 (Hepatocellular carcinoma)*Drechslera rostrata*104.0 ± 0.4078.7 ± 0.5117.0 ± 0.2217.0 ± 0.3*Eurotium tonophilum*125.0 ± 0.2059.0 ± 0.5054.5 ± 0.3059.0 ± 0.1H19.5 ± 0.417.5 ± 0.420.3 ± 0.410.4 ± 0.4H218.6 ± 0.49.5 ± 0.416.1 ± 0.419.7 ± 0.4Vinblastine Sulphate3.5 ± 0.259.7 ± 2.121.2 ± 0.92.93 ± 0.3[^1]Fig. 6The antitumor activity of Vinblastine sulphate as Reference Standard on four cell lines.

*Drechslera rostrata* extract showed an IC~50~ value of 104.0 μg/ml, 78.7 μg/ml, 117.0 μg/ml and 217.0 μg/ml against colon carcinoma cells, cervical carcinoma cells, larynx carcinoma cells and hepatocellular carcinoma cells, respectively.

*Eurotium tonpholium* extract showed an IC~50~ value of 125.0 μg/ml, 59.0 μg/ml, 54.5 μg/ml and 59.0 μg/ml against colon carcinoma cells, cervical carcinoma cells, larynx carcinoma cells and hepatocellular carcinoma cells, respectively.

H1 showed an IC~50~ value of 9.5 μg/ml, 17.5 μg/ml, 20.3 μg/ml and 10.4 μg/ml against colon carcinoma cells, cervical carcinoma cells, larynx carcinoma cells and hepatocellular carcinoma cells, respectively.

H2 showed an IC~50~ value of 18.6 μg/ml, 9.5 μg/ml, 16.1 μg/ml and 19.7 μg/ml against colon carcinoma cells, cervical carcinoma cells, larynx carcinoma cells and hepatocellular carcinoma cells, respectively.

Reference standard, Vinblastine sulphate showed an IC~50~ value of 3.5 μg/ml, 59.7 μg/ml, 21.2 μg/ml and 2.93 μg/ml against colon carcinoma cells, cervical carcinoma cells, larynx carcinoma cells and hepatocellular carcinoma cells, respectively.

*Drechslera rostrate extract*, *Eurotium* ***tonophilum*** extract, H1 and H2 showed a dose-dependent inhibitory effect on the growth of colon carcinoma cells, cervical carcinoma cells, larynx carcinoma cells and hepatocellular carcinoma cells.

4. Discussion and conclusion {#s0050}
============================

Natural products have provided the most important successes in the chemotherapy of cancer. Most of the major anticancer compounds are obtained from natural products which includes plants and microorganisms ([@b0095]). Earlier reports showed that the secondary metabolites from fungi provided an important group of new biological agents and having low toxicity on normal cells. Further, the secondary metabolites are low molecular weight compounds, exhibiting a potential anticancer activity. It is wondered that biological activity of the fungi extracts is associated with the endogenous environment of the plant ([@b0045]). It is observed that the existing anticancer drugs have a limited selectivity and high toxicity.

Researchers in the molecular and cellular biology are regularly identifying novel potential targets, which are specific or selective for cancer cells ([@b0085]). The effect of the extracts of endophytic fungi isolated from mangrove plants on the cancer cells as well as their effects on topoisomerase was reported ([@b0030]). The anticancer activity of compounds isolated from marine endophytic fungus *Aspergillus terreus* was reported ([@b0140]). A new Topo I isomerase inhibitor, (+)−3, 3, 7, 7, 8. 8- hexahydroxy-5, 5-dimethylbianthraquinone was recently isolated from mangrove endophytic fungi ([@b0145]).

The di-esters of 1, 2-benzenedicarboxylic acid (phthalic acid), commonly known as phthalates, are a group of man-made chemicals ([@b0065]).

There are many researches reporting isolation of phthalates from bacterial strains, streptomycetes, fungi, algae and plants. These compounds seem to play an important role in many areas ([@b0105]).

Although these compounds are not novel isolates, it is the first time that their antitumor activity is described in colon carcinoma cells, cervical carcinoma cells, larynx carcinoma cells and hepatocellular carcinoma cells.

In our study, effects on cell viability/proliferation were assessed by an MTT assay and all extracts and compounds tested significantly decreased cell viability and proliferation in one or more of the cell lines tested. The anti-proliferative effect of the compounds could be due to induction of cell death and/or cell cycle arrest.

Hela (cervical carcinoma) cell line was the most sensitive line to *Drechslera rostrata* extract and H2, HEp-2 (larynx carcinoma) cell line was the most sensitive line to *Eurotium tonophilum* extract and HCT-116 (colon carcinoma) cell line was the most sensitive line to H1 and Vinblastine sulphate. In fact, almost all the extracts and compounds, proved to have an antitumor activity in a dose-dependent manner in these cell lines. The IC~50~ value of H1 and H2 are found to be most promising compare to the extracts in all the four cell lines. The IC~50~ value of H1 was found to be 9.5 μg/ml against colon carcinoma cells. The IC~50~ value of H2 was found to be 9.5 μg/ml against cervical carcinoma cells.

This study demonstrates that the compounds H1 and H2 obtained from the fungus *Drechslera rostrata* (DSM 62596) and *Eurotium tonophilum* (ATCC 16440) have significant antitumor properties, as evaluated by performing MTT assay to check the % cell viability against HCT-116 (colon carcinoma), HeLa (cervical carcinoma), HEp-2 (larynx carcinoma) and HepG-2 (hepatocellular carcinoma) cells.
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[^1]: Values are expressed as mean ± SEM of 6 determinants. Symbols ND represents not determined.
